ArticleMolecular therapy oncolytics2017

TGF-β Inhibition Improves Oncolytic Herpes Viroimmunotherapy in Murine Models of Rhabdomyosarcoma.

Brian Hutzen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.